United Kingdom

People: Qiagen NV (QGEN.N)

QGEN.N on New York Stock Exchange

8:51pm BST
Change (% chg)

$-0.34 (-0.85%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Mardis, Elaine 

Prof. Dr. Elaine R. Mardis has served as Independent Member of the Supervisory Board of Qiagen N.V. since 2014. Elaine joined the Company’s Supervisory Board and its Science and Technology Committee in 2014. Since 2014 she has served on the Scientific Advisory Board of Ingenuity Systems, Inc. Dr. Mardis holds over two decades experience in DNA preparation and sequencing-based research. She is the Robert E. and Louise F. Dunn Distinguished Professor of Medicine at Washington University and also serves as Co-Director of its McDonnell Genome Institute where she has worked since 1993. Prof. Dr. Mardis serves on several study sections of the U.S. National Institutes of Health, is an editorial board member of Molecular Cancer Research, Annals of Oncology, and Disease Models and Mechanisms and acts as a reviewer for Nature and The New England Journal of Medicine. Prof. Dr. Mardis also serves on the scientific advisory boards of QIAGEN Silicon Valley (formerly Ingenuity) and Regeneron Genomics Center. Between 2008 and 2009 she served on the board of directors of Applied Biosytems, Inc. Prof. Dr. Mardis is also Professor in the Department of Genetics, with an adjunct appointment in the Department of Molecular Microbiology at Washington University. Prior to joining the Washington

Basic Compensation

Total Annual Compensation, USD 63,500
Restricted Stock Award, USD 9,866
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 73,366

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --